An analysis of financial protection and financing incidence of out-of-pocket health expenditures in Kazakhstan from 2018 to 2021.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
17 04 2024
Historique:
received: 18 01 2024
accepted: 15 04 2024
medline: 19 4 2024
pubmed: 18 4 2024
entrez: 17 4 2024
Statut: epublish

Résumé

Universal health coverage relies on providing essential medical services and shielding individuals from financial risks. Our study assesses the progressivity of out-of-pocket (OOP) payments, identifies factors contributing to healthcare expenditure inequality, and examines catastrophic health expenditures (CHE) prevalence in Kazakhstan from 2018 to 2021. Using retrospective analysis of National Statistics Bureau data, we employed STATA 13 version for calculations CHE incidence, progressivity, Lorenz and concentration curves. In 2020-2021, OOP expenditures in Kazakhstan decreased, reflecting a nearly twofold reduction in the CHE incidence to 1.32% and 1.24%, respectively. However, during these years, we observe a transition towards a positive trend in the Kakwani index to 0.003 and 0.005, respectively, which may be explained by household size and education level factors. Increased state financing and quarantine measures contributed to reduced OOP payments. Despite a low healthcare expenditure share in gross domestic product, Kazakhstan exhibits a relatively high private healthcare spending proportion. The low CHE incidence and proportional expenditure system suggest private payments do not significantly impact financial resilience, prompting considerations about the role of government funding and social health insurance in the financing structure.

Identifiants

pubmed: 38632372
doi: 10.1038/s41598-024-59742-9
pii: 10.1038/s41598-024-59742-9
pmc: PMC11024138
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8869

Subventions

Organisme : Science Committee of Science and Higher Education of the Ministry of Kazakhstan
ID : AP15473445

Informations de copyright

© 2024. The Author(s).

Références

J Health Econ. 1999 Jun;18(3):263-90
pubmed: 10537896
J Health Econ. 2016 Jul;48:89-106
pubmed: 27137844
Lancet Glob Health. 2023 Oct;11(10):e1629-e1639
pubmed: 37734805
PLoS One. 2016 Apr 11;11(4):e0152866
pubmed: 27064991
Bull World Health Organ. 2013 Aug 1;91(8):546-546A
pubmed: 23940398
J Prev Med Public Health. 2024 Jan;57(1):65-72
pubmed: 38062719
Health Serv Res. 2004 Dec;39(6 Pt 2):1927-50
pubmed: 15544638
BMC Health Serv Res. 2023 Aug 1;23(1):822
pubmed: 37528374
Cost Eff Resour Alloc. 2021 Sep 16;19(1):59
pubmed: 34530840
Health Policy Plan. 2024 Jan 9;39(1):4-21
pubmed: 37990623
Cost Eff Resour Alloc. 2021 Aug 4;19(1):47
pubmed: 34348717
Cost Eff Resour Alloc. 2019 Dec 17;17:28
pubmed: 31889916
Health Policy Plan. 2018 Apr 1;33(3):436-444
pubmed: 29346547
Int J Equity Health. 2019 Jun 17;18(1):92
pubmed: 31208413
J Health Econ. 2008 Mar;27(2):460-75
pubmed: 18179832
Soc Sci Med. 2024 Jan;340:116457
pubmed: 38086221

Auteurs

Askhat Shaltynov (A)

Epidemiology and Biostatistics Department, Semey Medical University, Semey, Kazakhstan. askhat.shaltynov@smu.edu.kz.

Yulia Semenova (Y)

School of Medicine, Nazarbayev University, Astana, Kazakhstan.

Madina Abenova (M)

Epidemiology and Biostatistics Department, Semey Medical University, Semey, Kazakhstan.

Assel Baibussinova (A)

Epidemiology and Biostatistics Department, Semey Medical University, Semey, Kazakhstan.

Ulzhan Jamedinova (U)

Epidemiology and Biostatistics Department, Semey Medical University, Semey, Kazakhstan.

Ayan Myssayev (A)

Department of the Science and Human Resources, Ministry of Healthcare of the Republic of Kazakhstan, Astana, Kazakhstan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH